South Korea to Sharply Increase R&D Support for New Drugs in 2008 (South Korea)
This article was originally published in PharmAsia News
Executive Summary
In an attempt to expand its reach in the global pharmaceutical market, South Korea has announced it will significantly increase financial support for drug discovery and development. In 2008, the Ministry of Science and Technology will boost the country's research and development budget by 52 percent to $100.3 million. The government hopes by pouring this amount of money into pharmaceuticals, South Korea will be able to produce one new drug every year until 2016. (Click here for more - May Require Paid Subscription
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.
EU Must Crack Down Harder On Fake Medical Devices, Says Innovator
Counterfeit copies of LifeVac Europe’s anti-choking devices have been registered on the EU’s EUDAMED database and continue to be sold on third-party platforms. Medtech Insight asked director of sales and marketing Matthew Banagan how the company deals with fake devices and what the authorities must do.